News | Published: Friday, November 21, 2025
The Centers for Medicare and Medicaid Services (CMS) has issued the 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System final rule. CMS has finalized a 2.6% increase to OPPS payment rates that reflects a market basket update of 3.3% reduced by a productivity adjustment of 0.7%. Read about additional provisions from the final rule below.
News | Published: Thursday, November 13, 2025
Congress passed legislation on Nov. 12 to fund the federal government, and shortly after, President Donald Trump signed the continuing resolution into law, ending the longest ever government shutdown after 43 days of gridlock.
News | Published: Monday, November 10, 2025
Kestra Medical Technologies, Ltd., a wearable medical device and digital healthcare company, announced the primary results from the ASSURE® WCD Clinical Evaluation Post-Approval Study (ACE-PAS), presented as a Late-Breaking Science session at the American Heart Association (AHA) Scientific Sessions 2025 in New Orleans, LA. ACE-PAS, the largest prospective real-world study of wearable defibrillators (WCDs) to date, confirmed the strong safety and effectiveness of the ASSURE WCD in clinical practice.
News | Published: Wednesday, November 5, 2025
Updated November 5, 2025
The Centers for Medicare and Medicaid Services (CMS) has released the 2026 Medicare Physician Fee Schedule (PFS) final rule. The conversion factor for practitioners participating in a qualified alternative payment model (APM) is $33.5675, a 3.77% increase from 2025. For practitioners not participating in an APM, the conversion factor is $33.4009, a 3.26% increase from 2025.
Partner News | Published: Friday, October 31, 2025
The study, "AI-Guided Quantitative Plaque Evaluation from CT to Identify Patients with Future Myocardial Infarction or Death," analyzed 6,550 symptomatic patients (48% male, mean age 59) over 4.4 years who underwent coronary computed tomography angiography (CCTA) with AI-based quantitative coronary CT analysis (AI-QCT) across international sites.
Partner News | Published: Wednesday, October 29, 2025
Kestra Medical Technologies, a wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using therapeutic intervention technologies that are intuitive, intelligent, and connected.
Partner News | Published: Tuesday, October 21, 2025
These latest updates build on the AMA CPT Editorial Panel's February 2025 decision to approve new Category III CPT codes for CaRi-Heart technology.
Partner News | Published: Tuesday, October 21, 2025
With this coverage breakthrough, more patients will benefit from Cleerly's ability to quantify and characterize coronary plaque noninvasively.
Partner News | Published: Tuesday, October 21, 2025
In his new role at PaceMate, he will drive the company’s AI ambitions forward with a focus on transforming data-driven insights into automatic actions, beginning with the transformation of manual workflows that slow down clinics and take up time that could be better spent on patients.
News | Published: Saturday, October 18, 2025
As the business of cardiovascular care evolves rapidly, cardiologists have a number of options for structuring their practices and engaging in strategic partnerships. At a packed mini-intensive session, physicians, legal experts and practice leaders shared candid insights into how hospital employment, capital-backed platforms and management services organizations (MSOs) are reshaping independent cardiology practices. The three-part session, part of CV Transforum Fall’25 in Austin, TX, explored practice model choices, key legal protections in strategic partnerships, and what it’s really like to work in a private equity (PE)-backed cardiology group.
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.